Xtant Medical | SC 13D/A:超过5%持股股东披露文件(修正)-OrbiMed Advisors LLC(52.7%),OrbiMed ROF II LLC(12.3%)
Xtant Medical | 4:持股变动声明-董事 Vizirgianakis Stavros G.
Xtant Medical | 4:持股变动声明-董事 MITCHELL-KELLER LORI D
Xtant Medical | 4:持股变动声明-董事 McNamara Robert
Xtant Medical | 4:持股变动声明-董事 Beeson Jonn R.
Xtant Medical | 4:持股变动声明-董事 BAKEWELL JOHN K
Xtant Medical | 4:持股变动声明-高管 Brandt Kevin D
Xtant Medical | 4:持股变动声明-高管 Neils Scott C
Xtant Medical | 4:持股变动声明-高管 Browne Sean E
Xtant Medical | D:发行公告
Xtant Medical | 4:持股变动声明-高管 Brandt Kevin D
Xtant Medical | 4:持股变动声明-高管 Browne Sean E
Xtant Medical | 4:持股变动声明-高管 Schallenberger Mark A.
Xtant Medical | 4:持股变动声明-高管 Neils Scott C
Xtant Medical | 4/A:持股变动声明(修正)-高管 Browne Sean E
Xtant Medical | SC 13G/A:超过5%持股股东披露文件(修正)-Altium Capital Management, LP EIN:(6.2%),Altium Growth Fund, LP EIN:(4.99%)等
Xtant Medical | 4:持股变动声明-高管 Neils Scott C
Xtant Medical | 4:持股变动声明-首席商务官 Brandt Kevin D
Xtant Medical | 4:持股变动声明-高管 Browne Sean E
Xtant Medical | 4:持股变动声明-高管 Schallenberger Mark A.
暂无数据
暂无数据